Clinical Trial Update: Lung Cancer in Women Treated With Anti-oestrogens anD Inhibitors of EGFR [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating anti-estrogens and EGFR inhibitors for stage IV lung cancer in women has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer

Snippet

Sponsor: Intergroupe Francophone de Cancerologie Thoracique | Conditions: Stage IV Lung Cancer | Phase 2 | Status: COMPLETED